Yoshihara, Motoko

Publishing since 1981 (Dinosaur)

Has published 225 publications in 30 years

Number of publications published per year by Yoshihara, Motoko. (Source : PubMed)

Distribution of publications types for Yoshihara, Motoko. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Sakuma Y, Takeuchi T, Nakamura Y, Yoshihara M, Matsukuma S, Nakayama H, Ohgane N, Yokose T, Kameda Y, Tsuchiya E, Miyagi Y. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src.  J. Pathol.  2010;220;5  
•  Fukuhara T, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K. Natural Course of Lugol-Voiding Lesions in Patients with Superficial Esophageal Squamous Cell Carcinoma.  Digestion  2010;82;1  
•  Wada Y, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Relationship between Helicobacter pylori Tyrosine-Phosphorylated CagA-Related Markers and the Development of Diffuse-Type Gastric Cancers: A Case-Control Study.  Digestion  2010;82;1  
•  Fukuhara T, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.  J. Clin. Gastroenterol.  2010;44;2  
•  Roberts SK, Weltman MD, Crawford DH, McCaughan GW, Sievert W, Cheng WS, Rawlinson W, Desmond PV, Marks PS, Yoshihara M, Rizkalla B, Depamphilis JK, Dore GJ. Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.  Hepatology  2009;50;4  
•  Hiyama T, Matsuo K, Urabe Y, Fukuhara T, Tanaka S, Yoshihara M, Haruma K, Chayama K. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.  J. Gastroenterol. Hepatol.  2009;24;8  
•  Domingo E, Lorvidhaya V, de Los Reyes R, Syortin T, Kamnerdsupaphon P, Lertbutsayanukul C, Vito-Cruz E, Tharavichitkul E, Jin K, Yoshihara M, Cupino N, Lertsanguansinchai P. Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.  Oncologist  2009;14;8  
•  Sumida T, Kitadai Y, Hiyama T, Shinagawa K, Tanaka M, Kodama M, Masuda H, Ito M, Tanaka S, Yoshihara M, Chayama K. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.  Cancer Sci.  2009;100;6  
•  Wada Y, Ito M, Takata S, Kitamura S, Takamura A, Tatsugami M, Imagawa S, Matsumoto Y, Tanaka S, Yoshihara M, Chayama K. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.  Hepatogastroenterology  2009;56;91-92  
•  Mouri R, Yoshida S, Tanaka S, Oka S, Yoshihara M, Chayama K. Evaluation and validation of computed virtual chromoendoscopy in early gastric cancer.  Gastrointest. Endosc.  2009;69;6  

[ See timeline ] [ See all publications ]